Letter to the EditorFull Access
Published Online:1 Feb 2002https://doi.org/10.1176/appi.ajp.159.2.315
- Cited by
- 31 August 2021 | Journal of Developmental and Physical Disabilities, Vol. 34, No. 3
- World Journal of Psychiatry, Vol. 12, No. 2
- World Journal of Psychiatry, Vol. 12, No. 2
- 2 December 2021
- World Journal of Clinical Cases, Vol. 9, No. 20
- 27 December 2020 | Expert Opinion on Drug Safety, Vol. 20, No. 3
- 15 June 2015 | Therapeutic Advances in Psychopharmacology, Vol. 5, No. 4
- 16 May 2011 | Therapeutic Advances in Psychopharmacology, Vol. 1, No. 2
- Journal of Psychiatric Practice, Vol. 16, No. 2
- Journal of Psychiatric Practice, Vol. 15, No. 6
- 1 July 2007 | The Canadian Journal of Psychiatry, Vol. 52, No. 7
- 7 August 2002 | Pharmacoepidemiology and Drug Safety, Vol. 11, No. 5